ROS-responsive EPO nanoparticles ameliorate ionizing radiation-induced hematopoietic injury

Biomater Sci. 2021 Sep 28;9(19):6474-6485. doi: 10.1039/d1bm00919b.

Abstract

Stimulus-responsive polymer materials have attracted much attention as drug carriers because of the ability to deliver drugs to the active site. Reactive oxygen species (ROS) play crucial roles in cellular signaling and regulation of oxygen homeostasis. However, ROS are present in abnormally high levels in many pathological environments. Based on the above points, three-arm poly(lactic-co-glycolic acid)-PO-poly(ethylene glycol) (3s-PLGA-PO-PEG or simply PP) was synthesized by using peroxalate esters (PO) as hydrogen peroxide-responsive linkages. PP was used to deliver promote hematopoietic recovery drugs erythropoietin (EPO) and EPO nanoparticles (EPO NPs) were prepared. We established a hematopoietic system injury model by ionizing radiation (IR) and unexpectedly found the good therapeutic effect of blank PP. Moreover, the administration of EPO NPs obviously decreased IR-induced ROS in bone marrow cells (BMCs) and reconstituted hematopoietic stem cells in BMCs. This study reveals a novel ROS-responsive polymer material that could be employed to remove excess ROS in the lesion and promote the efficacy of drug therapy.

MeSH terms

  • Drug Carriers
  • Erythropoietin*
  • Nanoparticles*
  • Radiation, Ionizing
  • Reactive Oxygen Species

Substances

  • Drug Carriers
  • Reactive Oxygen Species
  • Erythropoietin